Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity

CONCLUSION: Low-dose intravesical onabotA for DODU demonstrated a relatively shorter duration of efficacy than OAB. Nonetheless, the treatment improved both storage and voiding symptoms in patients with DODU without significant adverse effects.PMID:38569620 | PMC:PMC10990756 | DOI:10.5213/inj.2346228.114

Source: International Neurourology Journal - April 3, 2024 Category: Urology & Nephrology Authors: Hyun Seok Na Chung Lyul Lee Jae Sung Lim Ki Hak Song Ju Hyun Shin Jong Mok Park Ji Yong Lee Source Type: research